A phase III, multicenter, double-blind, randomized clinical trial to evaluate the efficacy and safety of ceftolozane/tazobactam plus metronidazole versus meropenem in Chinese participants with complicated intra-abdominal infections.
Int J Infect Dis
; 123: 157-165, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-35987467
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Intraabdominal Infections
/
Metronidazole
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Int J Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2022
Type:
Article
Affiliation country:
China